Curcumin limits the fibrogenic evolution of experimental steatohepatitis. [electronic resource]
Producer: 20100202Description: 104-15 p. digitalISSN:- 1530-0307
- Actins -- antagonists & inhibitors
- Alanine Transaminase -- antagonists & inhibitors
- Animals
- CD11b Antigen -- drug effects
- Cells, Cultured
- Chemokine CCL2 -- antagonists & inhibitors
- Choline -- administration & dosage
- Choline Deficiency
- Collagen Type I -- antagonists & inhibitors
- Curcumin -- pharmacology
- Diet
- Enzyme Inhibitors -- pharmacology
- Fatty Liver -- complications
- Hepatic Stellate Cells -- metabolism
- Humans
- Liver -- metabolism
- Liver Cirrhosis -- etiology
- Male
- Methionine -- administration & dosage
- Mice
- Mice, Inbred C57BL
- Muscle, Smooth -- metabolism
- Oxidative Stress -- drug effects
- Reactive Oxygen Species -- antagonists & inhibitors
- Tissue Inhibitor of Metalloproteinase-1 -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.